Impact BioMedical, Inc. (IBO) Stock Statistics & Valuation Metrics

Impact BioMedical, Inc. has a market cap or net worth of ―. The enterprise value is $7.88M.

Impact BioMedical, Inc. has 12,085,412 shares outstanding. The number of shares has decreased by -2.65% in one year.

Impact BioMedical, Inc.’s return on equity (ROE) is -0.48 and return on invested capital (ROIC) is 2.85%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Impact BioMedical, Inc. had revenue of 2.33M and earned -2.05M in profits. Earnings per share was -0.01.

In the last 12 months, operating cash flow was -3.44M and capital expenditures 0.00, giving a free cash flow of -3.44M billion.

Impact BioMedical, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Impact BioMedical, Inc. upcoming earnings date is ―, ―.

Impact BioMedical, Inc. as a current ratio of 0.25, with Debt / Equity ratio of 44.07%

In the past 12 months, Impact BioMedical, Inc. has paid 0.00 in taxes.

Impact BioMedical, Inc. EV to EBITDA ratio is -223.50, with an EV/FCF ratio of -87.78.

Impact BioMedical, Inc. has $1.32M in cash and marketable securities with C$9.14M in debt, giving a net cash position of $7.82M billion.

Gross margin is 100.00%, with operating margin of 23.67%, and net profit margin of -88.01%.

The average price target for Impact BioMedical, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―